Medication Adherence and Treatment-resistant Hypertension: a Review

Overview

Journal Drugs Context

Specialty Pharmacology

Date 2019 Feb 19

PMID 30774692

Citations 23

Authors

Mohammed Awais Hameed

Indranil Dasgupta

Affiliations

Soon will be listed here.

Abstract

Nonadherence is a common reason for treatment failure and treatment resistance. No matter how it is defined, it is a major issue in the management of chronic illnesses. There are numerous methods to assess adherence, each with its own strengths and weaknesses; however, no single method is considered the best. Nonadherence is common in patients with hypertension, and it is present in a large proportion of patients with uncontrolled blood pressure taking three or more antihypertensive agents. Availability of procedure-based treatment options for these patients has shed further light on this important issue with development of new methods to assess adherence. There is, however, no consensus on the management of nonadherence, which reflects the complex interplay of factors responsible for it.

Citing Articles

Supporting General Practitioners and people with hypertension to maximise medication use to control blood pressure: the contribution of Collective Intelligence to the development of the 'Maximising Adherence, Minimising Inertia' (MIAMI) intervention.

C Morrissey E, Harney O, Hogan M, Murphy P, OGrady L, Byrne M Health Psychol Behav Med. 2024; 12(1):2404038.

PMID: 39315072 PMC: 11418048. DOI: 10.1080/21642850.2024.2404038.

Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach.

Nardoianni G, Pala B, Scoccia A, Volpe M, Barbato E, Tocci G High Blood Press Cardiovasc Prev. 2024; 31(2):99-112.

PMID: 38616212 PMC: 11043106. DOI: 10.1007/s40292-024-00634-4.

Effectiveness of the knowledge, attitude, practice intervention model in the management of hypertension in the elderly.

Xu L, Gao Z, He M, Yang M J Clin Hypertens (Greenwich). 2024; 26(5):465-473.

PMID: 38468407 PMC: 11088428. DOI: 10.1111/jch.14770.

Prevalence, Risk Factors and Cardiovascular Comorbidities of Resistant Hypertension among Treated Hypertensives in a Nigerian Population.

Abiodun O, Anya T, Chukwu J, Adekanmbi V Glob Heart. 2024; 19(1):17.

PMID: 38344745 PMC: 10854423. DOI: 10.5334/gh.1296.

Factors predicting medication adherence among coronary artery disease patients in Saudi Arabia: A descriptive study.

Almarwani A, Almarwani B Saudi Med J. 2023; 44(9):904-911.

PMID: 37717959 PMC: 10505289. DOI: 10.15537/smj.2023.44.9.20230293.

References

Waeber B, Leonetti G, Kolloch R, McInnes G . Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study. J Hypertens. 1999; 17(7):1041-5. DOI: 10.1097/00004872-199917070-00022. View

Steiner J, Earnest M . The language of medication-taking. Ann Intern Med. 2000; 132(11):926-30. DOI: 10.7326/0003-4819-132-11-200006060-00026. View

Burnier M, Schneider M, Chiolero A, Stubi C, Brunner H . Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens. 2001; 19(2):335-41. DOI: 10.1097/00004872-200102000-00022. View

Liu H, Golin C, Miller L, Hays R, Beck C, Sanandaji S . A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001; 134(10):968-77. DOI: 10.7326/0003-4819-134-10-200105150-00011. View

Turner B, Hecht F . Improving on a coin toss to predict patient adherence to medications. Ann Intern Med. 2001; 134(10):1004-6. DOI: 10.7326/0003-4819-134-10-200105150-00015. View

Claxton A, Cramer J, Pierce C . A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23(8):1296-310. DOI: 10.1016/s0149-2918(01)80109-0. View

Cushman W, Ford C, Cutler J, Margolis K, Davis B, Grimm R . Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002; 4(6):393-404. DOI: 10.1111/j.1524-6175.2002.02045.x. View

Hajjar I, Kotchen T . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290(2):199-206. DOI: 10.1001/jama.290.2.199. View

Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J . Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003; 6(5):566-73. DOI: 10.1046/j.1524-4733.2003.65269.x. View

10.

Lau D, Nau D . Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004; 27(9):2149-53. DOI: 10.2337/diacare.27.9.2149. View

11.

Garg J, Elliott W, Folker A, Izhar M, Black H . Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens. 2005; 18(5 Pt 1):619-26. DOI: 10.1016/j.amjhyper.2004.11.021. View

12.

Benner J, Pollack M, Smith T, Bullano M, Willey V, Williams S . Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy. Am J Health Syst Pharm. 2005; 62(14):1468-75. DOI: 10.2146/ajhp040419. View

13.

Ogedegbe G, Schoenthaler A . A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens (Greenwich). 2006; 8(3):174-80. PMC: 8109348. DOI: 10.1111/j.1524-6175.2006.04872.x. View

14.

Simpson S, Eurich D, Majumdar S, Padwal R, Tsuyuki R, Varney J . A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006; 333(7557):15. PMC: 1488752. DOI: 10.1136/bmj.38875.675486.55. View

15.

Woltmann E, Valenstein M, Welsh D, Lee T, Wolschon P, Grabowski J . Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychiatr Serv. 2007; 58(6):864-7. DOI: 10.1176/ps.2007.58.6.864. View

16.

Gossec L, Tubach F, Dougados M, Ravaud P . Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci. 2007; 334(4):248-54. DOI: 10.1097/MAJ.0b013e318068dde8. View

17.

Grassi D, Oflaherty M, Pellizzari M, Bendersky M, Rodriguez P, Turri D . Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. J Clin Hypertens (Greenwich). 2008; 10(9):662-7. PMC: 8673337. DOI: 10.1111/j.1751-7176.2008.00001.x. View

18.

Yakovlevitch M, Black H . Resistant hypertension in a tertiary care clinic. Arch Intern Med. 1991; 151(9):1786-92. View

19.

Salles G, Cardoso C, Muxfeldt E . Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008; 168(21):2340-6. DOI: 10.1001/archinte.168.21.2340. View

20.

Rose A, Berlowitz D, Manze M, Orner M, Kressin N . Intensifying therapy for hypertension despite suboptimal adherence. Hypertension. 2009; 54(3):524-9. PMC: 2739677. DOI: 10.1161/HYPERTENSIONAHA.109.133389. View